Vermont Companion Aide Pilot Project: Person-Centered Dementia Care in Nursing Homes

What the Companion Aide Pilot Project Did

Vermont's Companion Aide Pilot Project was a state-backed initiative that ran from March 2015 through June 30, 2017, designed to reduce the use of antipsychotic medications in nursing homes by providing one-on-one, non-pharmacological support to residents living with dementia. Instead of relying on chemical sedation to manage behavioral symptoms like agitation, exit-seeking, or sundowning, companion aides worked directly with individual residents using person-centered techniques — redirecting anxiety, providing meaningful engagement, and addressing the unmet needs that drive challenging behaviors in the first place.

The project emerged from a wider national push by the Centers for Medicare & Medicaid Services (CMS) to reduce inappropriate antipsychotic prescribing in long-term care facilities. Vermont's approach targets the root cause: residents with dementia often exhibit behavioral symptoms not because they need medication, but because they are bored, frightened, in pain, or overstimulated in institutional environments that were not designed around their cognitive needs.

Why Antipsychotic Reduction Matters for Vermont Families

The scale of the problem is significant. Nationally, antipsychotic medications have been prescribed to nursing home residents with dementia at alarming rates, despite FDA black-box warnings about increased mortality risk in elderly patients with dementia-related psychosis. These drugs — often used off-label to manage behaviors like wandering, repetitive vocalization, and resistance to care — carry serious side effects including falls, sedation, metabolic changes, and stroke.

For families navigating Vermont's long-term care system, this creates a direct concern. When a parent moves into a nursing facility — where semi-private rooms average approximately $163,500 annually and private rooms reach $174,800 to $186,333 — the expectation is that high-quality clinical care justifies the cost. Learning that behavioral management relies heavily on chemical sedation rather than individualized engagement undermines that expectation.

The Companion Aide Pilot Project gave families a concrete benchmark: it was designed to enhance person-centered care and reduce inappropriate antipsychotic medication use.

How the Program Worked in Practice

Companion aides were trained staff members who provided individualized, non-pharmacological interventions to residents exhibiting behavioral symptoms associated with dementia. Their approach included:

• Behavioral root-cause analysis: Before any intervention, the aide worked to identify what was triggering the behavior. Is the resident in physical discomfort? Are they responding to environmental overstimulation? Do they have an unmet social need? This assessment-first approach contrasts sharply with the prescribe-first model.
• Meaningful activity programming: Companion aides engaged residents in activities matched to their cognitive level and personal history — music they loved, tasks that connect to former occupations, sensory experiences. This was not generic "arts and crafts" but individualized programming built around each resident's biography.
• Environmental modification: Adjusting lighting, noise levels, room arrangement, and daily routines to reduce the environmental triggers that provoke agitation and exit-seeking behavior.
• Communication techniques: Using the specialized dementia communication skills that Vermont regulations already require of all direct-care staff in licensed facilities. Companion aides took these skills further, spending extended one-on-one time that regular staffing ratios often do not allow.

What This Means for Facility Evaluation

If your family is evaluating nursing facilities or memory care placements in Vermont, the Companion Aide Pilot Project provided a useful quality signal. Facilities that participated — or that have adopted similar person-centered behavioral programs — demonstrate a commitment to non-pharmacological care that goes beyond regulatory minimums.

When touring facilities, ask specifically about:

• Antipsychotic prescribing rates: Facilities are required to report these to CMS, and the data is publicly available through Medicare's Care Compare. Lower rates generally indicate stronger behavioral programming.
• Companion aide or equivalent programming: Does the facility employ staff specifically dedicated to one-on-one behavioral support, or does behavioral management fall entirely on the regular care team?
• Specialized Care Unit (SCU) approval: Vermont does not issue a standalone "memory care" license. Facilities must obtain explicit approval from the Division of Licensing and Protection (DLP) to operate a Dementia Special Care Unit. This approval requires submitting physical design plans, admission and discharge policies, staffing ratios, and specialized training curricula to the state — it is a formal review, not a marketing label.
• Staff training beyond minimums: Vermont requires 8 hours of pre-service dementia training for SCU staff and 2 hours of annual continuing education. Facilities with companion aide programs typically invest well beyond these floors.

The Connection to Choices for Care Coverage

For families using Vermont's Choices for Care Medicaid waiver to fund nursing facility care, the quality of behavioral programming directly affects the care experience but does not change the financial mechanics. Medicaid covers 100% of licensed nursing facility care for residents approved in the High or Highest Need Groups, with the Highest Need Group serving as the entitlement tier and the resident contributing their monthly income minus a $79.93 Personal Needs Allowance as their patient share.

The financial eligibility rules — the $2,000 countable asset limit for single applicants, the 60-month lookback period on transfers, and the spousal impoverishment protections (Community Spouse Resource Allowance of up to $162,660) — apply regardless of which facility the resident enters. But the quality of dementia programming varies dramatically between facilities, and programs like the Companion Aide Pilot Project represent the kind of differentiation families should be weighing alongside cost and location.

The Enhanced Residential Care (ERC) option under Choices for Care offers another path: Medicaid covers clinical and personal care in approved Level III Residential Care Homes and Assisted Living Residences, while the resident pays room and board privately. Families choosing between a nursing facility with strong behavioral programming and a smaller residential setting with an approved SCU should evaluate both the clinical capabilities and the person-centered care philosophy.

Finding Facilities That Prioritize Non-Pharmacological Care

Start with the DLP's public facility directories at dlp.vermont.gov to identify licensed facilities with approved Dementia Special Care Units. Cross-reference these with Medicare's Care Compare tool to review antipsychotic prescribing rates and inspection survey results. Then call or visit each facility and ask directly about their behavioral intervention programming, companion aide staffing, and how they handle escalating dementia behaviors before turning to medication.

The Vermont Dementia & Memory Care Guide includes a facility evaluation scorecard that covers these quality markers alongside the financial and regulatory factors — so you can compare facilities systematically rather than relying on marketing materials and first impressions.

See more Vermont guides →